Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults.

about

Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults.

Item

http://www.wikidata.org/entity/Q36343699

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@ast

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@en

type

Item

label

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@ast

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@en

prefLabel

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@ast

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@en

P1476

Complete manuscript Title: Cha ...... IV-infected cART naïve adults.

@en

P2093

Ann-Brit Eg Hansen

http://www.w3.org/2001/XMLSchema#string

Court Pedersen

http://www.w3.org/2001/XMLSchema#string

Inger Hee Mathiesen

http://www.w3.org/2001/XMLSchema#string

Jan Gerstoft

http://www.w3.org/2001/XMLSchema#string

Julie Christine Gaardbo

http://www.w3.org/2001/XMLSchema#string

Mohammad Salem

http://www.w3.org/2001/XMLSchema#string

P2860

Skeletal remodeling in health and disease

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.

Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.

Minireview: the OPG/RANKL/RANK system.

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.

Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation

P2888

s12879-017-2368-y

P304

262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-017-2368-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Ullum

Susanne D Nielsen

Niels Obel

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084738253

http://www.w3.org/2001/XMLSchema#string

P698

28399815

http://www.w3.org/2001/XMLSchema#string

P932

5387326

http://www.w3.org/2001/XMLSchema#string